Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Some participants in early studies experienced slight increases in heart rate or mild rhythm disturbances
In patients with type 2 diabetes mellitus, semaglutide tablets produced clinically significant reduction from baseline in HbA1c compared with placebo
Imagine Drucker submitting a grant proposal today titled "Investigating Gila Monster Venom Proteins for Potential Therapeutic Applications." How would reviewers respond to: Unclear commercial potential No obvious connection to existing treatment paradigms High risk of "failure" (most venom studies don't yield drugs) Difficult to measure short-term impact Traditional funding metrics, publication counts, citation indices, immediate clinical relevance, would likely work against such proposals
Lyophilized MTII should be stored at -20C and protected from light and moisture
